Bayer Alerts Shareholders More Yaz Lawsuits to Settle

The Web’s largest source for information on Yaz research, side effects and legal news is available at the Yaz Resource Center. Visit http://www.YazLawsuit.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

Dallas, TX (PRWEB) October 05, 2012

The Yaz Resource Center, a patient advocacy group, is alerting women prescribed the birth control drugs Yaz or Yasmin that they have been linked to blood clot injuries. Also, the manufacturer, Bayer, has started settling some injury claims. However, only certain claims may qualify and the time to file is limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen linking the hormone in Yaz to blood clots. On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.

Due to the number of patients filing a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the cases. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.

According to Bloomberg News on July 31st, Bayer’s second quarter stockholder newsletter stated they have now begun settling the Yaz lawsuits, with as many as 1900 resolved so far at an average of around $212,000. They have also reserved up to $610 million to settle more of the cases, but indicated they are only settling those related to blood clots.

In The Madison Record on July 11, 2012, special court master Stephen Saltzburg, who is overseeing the negotiations, estimated Yaz lawsuit settlements could be concluded within a year.

The news of Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.


Contact